Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
65.6M
-
Shares change
-
+1.47M
-
Total reported value, excl. options
-
$222M
-
Value change
-
+$5.69M
-
Put/Call ratio
-
0.63
-
Number of buys
-
79
-
Number of sells
-
-45
-
Price
-
$3.39
Significant Holders of Xeris Biopharma Holdings, Inc. - COM (XERS) as of Q4 2024
176 filings reported holding XERS - Xeris Biopharma Holdings, Inc. - COM as of Q4 2024.
Xeris Biopharma Holdings, Inc. - COM (XERS) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.6M shares
.
Largest 10 shareholders include BlackRock, Inc. (10.8M shares), VANGUARD GROUP INC (7.9M shares), GEODE CAPITAL MANAGEMENT, LLC (3.35M shares), STATE STREET CORP (3.34M shares), Rosalind Advisors, Inc. (3.1M shares), MORGAN STANLEY (2.88M shares), AIGH Capital Management LLC (2.57M shares), RENAISSANCE TECHNOLOGIES LLC (2.1M shares), CAXTON CORP (2.02M shares), and MILLENNIUM MANAGEMENT LLC (1.95M shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.